ClinicalTrialsFinder

Mast Cell-mediated Neuroinflammation Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Topical Ketotifen 0.25% for Secondary Vestibulodynia

VulvodyniaProvoked VestibulodyniaSecondary Provoked Vestibulodynia+4 more
Center for Vulvovaginal Disorders54 enrolled3 locationsNCT07257029